Disease | amyloidosis |
Phenotype | C0002395|alzheimer disease |
Sentences | 1 |
PubMedID- 22534039 | S.g. holds the following issued patents: “method of screening for modulators of amyloid formation” (us patent 5,348,963); “treatment of amyloidosis associated with alzheimer disease using modulators of protein phosphorylation (us patent 5,385,915); “treatment of amyloidosis associated with alzheimer disease” (us patent 5,242,932); and “use of phosphoprotein patterns for diagnosis of neurological and psychiatric disorders” (us patent 4,874,694). |
Page: 1